Murae Organisor Ltd
Incorporated in 2012, Murae Organisor Ltd
is in the business of pharma commodities
trading[1]
- Market Cap ₹ 123 Cr.
- Current Price ₹ 1.32
- High / Low ₹ 2.72 / 1.03
- Stock P/E 26.0
- Book Value ₹ 2.85
- Dividend Yield 0.00 %
- ROCE 0.79 %
- ROE 0.13 %
- Face Value ₹ 2.00
Pros
- Stock is trading at 0.46 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -45.0% over past five years.
- Company has a low return on equity of 6.02% over last 3 years.
- Company might be capitalizing the interest cost
- Company has high debtors of 1,543 days.
- Working capital days have increased from 2,490 days to 6,342 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 9m | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 0 | 9 | 19 | 23 | 35 | 51 | 55 | 41 | 21 | 14 | 3 | 340 | |
0 | 0 | 9 | 18 | 23 | 34 | 47 | 54 | 49 | 25 | 13 | 4 | 333 | |
Operating Profit | 0 | 0 | 0 | 1 | 0 | 2 | 3 | 1 | -8 | -4 | 1 | -1 | 6 |
OPM % | 2% | 3% | 2% | 4% | 7% | 2% | -19% | -21% | 7% | -44% | 2% | ||
0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 9 | 8 | 2 | 2 | 0 | |
Interest | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit before tax | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 3 | 3 | 0 | 6 |
Tax % | 31% | 44% | 33% | 27% | 27% | 26% | 25% | 28% | 29% | 29% | |||
0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 2 | 2 | 0 | 5 | |
EPS in Rs | 0.20 | 0.32 | 0.46 | 0.83 | 0.04 | 0.00 | 0.05 | 0.05 | 0.00 | 0.04 | |||
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | -45% |
3 Years: | -60% |
TTM: | 8246% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | -50% |
3 Years: | -18% |
TTM: | 654% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | -20% |
3 Years: | -37% |
1 Year: | -21% |
Return on Equity | |
---|---|
10 Years: | 9% |
5 Years: | 6% |
3 Years: | 6% |
Last Year: | 0% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.01 | 0.01 | 0.01 | 0.11 | 0.11 | 0.31 | 0.31 | 6 | 6 | 12 | 12 | 49 | 139 |
Reserves | 0 | 0 | 1 | 1 | 1 | 5 | 6 | 8 | 8 | 4 | 6 | 6 | 126 |
0 | 0 | 1 | 2 | 2 | 7 | 10 | 9 | 11 | 9 | 9 | 0 | 260 | |
0 | 0 | 3 | 6 | 7 | 7 | 8 | 12 | 2 | 3 | 1 | 64 | 24 | |
Total Liabilities | 0 | 0 | 5 | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | 120 | 548 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 |
0 | 0 | 5 | 9 | 11 | 19 | 23 | 32 | 27 | 28 | 28 | 120 | 548 | |
Total Assets | 0 | 0 | 5 | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | 120 | 548 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 0 | -2 | -0 | 0 | -7 | -0 | -3 | -7 | 3 | 0 | -16 | |
0 | 0 | -0 | -0 | -0 | -0 | -0 | -3 | 3 | 0 | 0 | -0 | |
0 | 0 | 2 | 1 | -0 | 7 | 1 | 7 | 3 | -3 | -0 | 28 | |
Net Cash Flow | 0 | 0 | 0 | 0 | -0 | -0 | 0 | -0 | -1 | -0 | -0 | 12 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 125 | 87 | 56 | 111 | 78 | 112 | 95 | 261 | 217 | 1,543 | ||
Inventory Days | 71 | 78 | 108 | 91 | 86 | 97 | 122 | 179 | 392 | 1,439 | ||
Days Payable | 113 | 107 | 83 | 77 | 54 | 83 | 10 | 18 | -25 | 7 | ||
Cash Conversion Cycle | 82 | 58 | 82 | 125 | 111 | 126 | 207 | 422 | 635 | 2,975 | ||
Working Capital Days | 81 | 54 | 58 | 116 | 98 | 126 | 222 | 431 | 698 | 6,342 | ||
ROCE % | 0% | 22% | 21% | 22% | 25% | 24% | 17% | 4% | 12% | 12% | 1% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
2h - Resignation of Company Secretary and Compliance Officer.
-
Announcement under Regulation 30 (LODR)-Resignation of Director
1 Apr - Ms. Khyati Kanaiyalal Patel resigned as Non-Executive Director.
-
Annoucement Under Regulation 30 Of SEBI (LODR) Regulations, 2015- Reconstitution Of Committee.
29 Mar - Change in board members and appointments.
-
Announcement under Regulation 30 (LODR)-Change in Directorate
29 Mar - Change in directors and appointments at Murae Organisor.
-
Board Meeting Outcome for Outcome And Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
29 Mar - Change in directors and appointment of new managing director.
Business Overview:[1][2][3]
a) MOL is in the business of manufacturing Pharmaceutical, Nutraceutical, Ayurvedic
Herbal products, and trading of pharma
products.
b) It acts as a commission agent in pharma products etc.
c) It provides premium cattle feed which is formulated to support livestock health and performance, while its fertilizers and chemicals are designed to optimize crop yields and ensure safety.
d) It also offers expertise in the gold sector, providing insights and services related to this precious metal